Preliminary results on clinical effects of probiotic Lactobacillus salivarius LS01 in children affected by atopic dermatitis

Journal of Clinical Gastroenterology

Volumn 48, Issue , 2014, Pages S34-S36

  Niccoli, Antonio A ^a   Artesi, Anna L ^a   Candio, Francesco ^a   Ceccarelli, Sara ^a   Cozzali, Rita ^a   Ferraro, Luigi ^a   Fiumana, Donatella ^a   Mencacci, Manuela ^a   Morlupo, Maurizio ^a   Pazzelli, Paola ^a   Rossi, Laura ^a   Toscano, Marco ^b   Drago, Lorenzo ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Atopic dermatitis; Gut microbiota; Immune system; Probiotics

Indexed keywords

EMOLLIENT AGENT; PROBIOTIC AGENT; STEROID;

ABSENCE OF SIDE EFFECTS; ATOPIC DERMATITIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE COURSE; DRUG EFFICACY; FEMALE; HUMAN; INFANT; LACTOBACILLUS SALIVARIUS; MALE; NEWBORN; NONHUMAN; QUALITY OF LIFE; SKIN PRURITUS; STEROID THERAPY; TREATMENT DURATION; CLASSIFICATION; CLINICAL TRIAL; DERMATITIS, ATOPIC; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INTESTINE; ITALY; LACTOBACILLUS; MICROBIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PRURITUS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFANT; INFANT, NEWBORN; INTESTINES; ITALY; LACTOBACILLUS; MALE; PROBIOTICS; PRURITUS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84916596332     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000233     Document Type: Conference Paper

References (27)

1. Girolomoni G, Abeni D, Masini C, et al. The epidemiology of atopic dermatitis in Italian school children. Allergy. 2003; 58:420-425.
2. Monti F, Agostini F, Gobbi F, et al. Quality of life measures in Italian children with atopic dermatitis and their families. Ital J Pediatr. 2011;37:59.
3. Beasley R. Worldwide variation in the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema: ISAC. The International Study of Asthma and Allergy in Childhood (ISAAC) Steering Committee. Lancet. 1998;351:1125-1132.
4. Rehal B, Armstrong A. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010. PLoS One. 2011;6: e17520.
5. Kim NY, Ji GE. Effects of probiotics on the prevention of atopic dermatitis. Korean J Pediatr. 2012;55:193-201.
6. Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol. 1999;103(pt 1):125-138.
7. Iemoli E, Trabattoni D, Parisotto S, et al. Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. J Clin Gastroenterol. 2012;46(suppl):S33-S40.
8. Simon G, Gorbach SL. Intestinal flora in health and disease. Gastroenterology. 1994;86:74-93.
9. Drago L, Toscano M, Pigatto PD. Probiotics: immunomodulatory properties in allergy and eczema. G Ital Dermatol Venereol. 2013;148:505-514.
10. Ji G. Probiotics in primary prevention of atopic dermatitis. Forum Nutr. 2009;61:117-128.
11. Roudsari MR, Karimi R, Mortazavian AM. Health effects of probiotics on the skin. Crit Rev Food Sci Nutr. 2013 Dec 23. [Epub ahead of print].
12. Douek D. HIV disease progression: immune activation, microbes, and a leaky gut. Top HIV Med. 2007;15:114-117.
13. Kamat A, Ancuta P, Blumberg RS, et al. Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation. PLoS One. 2010;5:e15533.
14. Chun TW, Justement JS, Sanford C, et al. Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals. Proc Natl Acad Sci U S A. 2004;101:2464-2469.
15. Vanderhoof JA. Probiotics in allergy management. J Pediatr Gastroenterol Nutr. 2008;47(suppl 2):S38-S40.
16. Rosenfeldt V, Benfeldt E, Nielsen SD, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol. 2003;111:389-395.
17. Betsa GI, Papadavid E, Falagas ME. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am J Clin Dermatol. 2008;9:93-103.
18. Boyle RJ, Tang MLK. The role of probiotics in the management of allergic disease. Clin Exp Allergy. 2006;36:568-576.
19. Eichenfield LF. Consensus guidelines in diagnosis and treatment of atopic dermatitis. Allergy. 2004;59(suppl 78):86-92.
20. Schmitt J, Langan S, Williams HC, European Dermato- Epidemiology Network. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol. 2007;120:1389-1398.
21. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol. 2003;112(suppl):S118-S127.
22. Weston S, Halbert A, Richmond P, et al. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child. 2005;90:892-897.
23. Isolauri E, Arvola T, Sütas Y, et al. Probiotics in the management of eczema. Clin Exp Allergy. 2000;30: 1604-1610.
24. Drago L, Toscano M, De Vecchi E, et al. Changing of fecal flora and clinical effect of L. Salivarius LS01 in adults with atopic dermatitis. J Clin Gastroenterol. 2012;46(suppl): S56-S63.
25. Drago L, Nicola L, Iemoli E, et al. Strain-dependent release of cytokines modulated by Lactobacillus salivarius human isolates in an in vitro model. BMC Res Notes. 2010;3:44-48.
26. Murch SH. Toll of allergy reduced by probiotics. Lancet. 2001;357:1057-1059.
27. Brouwer ML, Wolt-Plompen SA, Dubois AE, et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy. 2006; 36:899-906.